FOLFIRINOX for 2nd-line Treatment of BTC

Clinical trial NCT03778593 · COMPLETED

Trial details

NCT number: NCT03778593
Sponsor: Dong-A University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2019-03-01
Primary completion: 2019-03-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.